iSpecimen (ISPC) Institutional Ownership $1.27 +0.04 (+3.25%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for iSpecimen (NASDAQ:ISPC)CurrentInstitutional OwnershipPercentage13.62%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$57.77KNumber ofInstitutional Sellers(last 12 months)0 Get ISPC Insider Trade Alerts Want to know when executives and insiders are buying or selling iSpecimen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ISPC Institutional Buying and Selling by Quarter iSpecimen Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Bridgeway Capital Management LLC21,800$58K0.0%N/A2.271% 7/22/2022 Grimes & Company Inc.62,014$135K0.0%+78.3%0.699% 5/18/2022Teton Advisors Inc.40,000$215K0.0%N/A0.454% 5/11/2022Bleichroeder LP65,834$666K0.1%-80.8%0.747% 5/6/2022 Grimes & Company Inc.34,771$187K0.0%N/A0.394% 2/15/2022Kepos Capital LP190,000$1.48M0.1%-15.6%2.177% 2/10/2022Bleichroeder LP342,180$2.83M0.4%-44.6%3.920% 2/8/2022Main Street Financial Solutions LLC10,500$82K0.0%N/A0.120% 11/16/2021Bleichroeder LP618,180$3.61M0.6%+3.0%8.835% 11/9/2021BlackRock Inc.6,007$35K0.0%N/A0.086% 10/27/2021Telemus Capital LLC24,400$142K0.0%N/A0.352% 8/17/2021Bleichroeder LP600,291$4.33M0.7%N/A8.671% 8/12/2021Kepos Capital LP225,000$1.63M0.1%N/A3.466% 8/11/2021Susquehanna International Group LLP11,842$85K0.0%N/A0.182% (Data available from 1/1/2016 forward) ISPC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ISPC shares? During the previous two years, the following institutional investors and hedge funds held shares of iSpecimen shares: Bridgeway Capital Management LLC ($58K).Learn more on ISPC's institutional investors. What percentage of iSpecimen stock is owned by institutional investors? 13.62% of iSpecimen stock is owned by institutional investors. Learn more on ISPC's institutional investor holdings. Which institutional investors have been buying iSpecimen stock? The following institutional investors have purchased iSpecimen stock in the last 24 months: Bridgeway Capital Management LLC ($21.80K). How much institutional buying is happening at iSpecimen? Institutional investors have bought a total of 21,800 shares in the last 24 months. This purchase volume represents approximately $57.77K in transactions. Related Companies DRCT Institutional Ownership CHR Institutional Ownership VS Institutional Ownership GLXG Institutional Ownership BIAF Institutional Ownership QH Institutional Ownership RVYL Institutional Ownership CISO Institutional Ownership SPPL Institutional Ownership INTJ Institutional Ownership This page (NASDAQ:ISPC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.